|
|
||||||||
Introduction: Since Ymer & Herington (1985) refocused attention on the serum growth hormone (GH) binding protein (GHBP), it has attracted considerable research effort. Despite this, much remains to be resolved regarding its physiological function(s) and its regulation (which provides clues to function). The presence of a high affinity GHBP has significant implications for understanding the growth process, for understanding maternal control of foetal development and for attempts to enhance growth using genetically engineered GH analogues. To date, these implications have not been adequately explored.
Although there is evidence for a low affinity high capacity GHBP (Baumann & Shaw 1990), the present review will focus on the high affinity GHBP. It will summarize what is known regarding distribution, regulation and suggested roles of the high affinity GHBP. Evidence that GHBP has a significant role in the endocrinology of pregnancy and control of foetal growth will be discussed. Since progress in GHBP
This article has been cited by other articles:
![]() |
K. Pazaitou-Panayiotou, T. Kelesidis, I. Kelesidis, A. Kaprara, J. Blakeman, I. Vainas, A. Mpousoulegas, C. J Williams, and C. Mantzoros Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer Eur. J. Endocrinol., February 1, 2007; 156(2): 187 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Wallace, W. J. Abbott-Johnson, D. H. G. Crawford, R. Barnard, J. M. Potter, and R. C. Cuneo GH Treatment in Adults with Chronic Liver Disease: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2751 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Guan, Y. Zhang, J. Jiang, C. A. Baumann, R. A. Black, G. Baumann, and S. J. Frank Phorbol Ester- and Growth Factor-Induced Growth Hormone (GH) Receptor Proteolysis and GH-Binding Protein Shedding: Relationship to GH Receptor Down-Regulation Endocrinology, March 1, 2001; 142(3): 1137 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Le Roith, C. Bondy, S. Yakar, J.-L. Liu, and A. Butler The Somatomedin Hypothesis: 2001 Endocr. Rev., February 1, 2001; 22(1): 53 - 74. [Abstract] [Full Text] |
||||
![]() |
M. Ballesteros, K.-C. Leung, R. J. M. Ross, T. P. Iismaa, and K. K. Y. Ho Distribution and Abundance of Messenger Ribonucleic Acid for Growth Hormone Receptor Isoforms in Human Tissues J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2865 - 2871. [Abstract] [Full Text] |
||||
![]() |
T. Amit, M. B. H. Youdim, and Z.'e. Hochberg Does Serum Growth Hormone (GH) Binding Protein Reflect Human GH Receptor Function? J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 927 - 932. [Abstract] [Full Text] |
||||
![]() |
L. Rui, S. F. Archer, L. S. Argetsinger, and C. Carter-Su Platelet-derived Growth Factor and Lysophosphatidic Acid Inhibit Growth Hormone Binding and Signaling via a Protein Kinase C-dependent Pathway J. Biol. Chem., January 28, 2000; 275(4): 2885 - 2892. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung, N. Doyle, and K. K. Y. Ho Characterization of a Low Affinity Binding Protein for Growth Hormone in Rat Serum Endocrinology, January 1, 2000; 141(1): 138 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Amit, O. Bar-Am, F. Dastot, M. B. H. Youdim, S. Amselem, and Z.'e. Hochberg The Human Growth Hormone (GH) Receptor and Its Truncated Isoform: Sulfhydryl Group Inactivation in the Study of Receptor Internalization and GH-Binding Protein Generation Endocrinology, January 1, 1999; 140(1): 266 - 272. [Abstract] [Full Text] |
||||
![]() |
A. Edens and F. Talamantes Alternative Processing of Growth Hormone Receptor Transcripts Endocr. Rev., October 1, 1998; 19(5): 559 - 582. [Abstract] [Full Text] |
||||
![]() |
I. G. Camarillo, G. Thordarson, Y. N. Ilkbahar, and F. Talamantes Development of a Homologous Radioimmunoassay for Mouse Growth Hormone Receptor Endocrinology, August 1, 1998; 139(8): 3585 - 3589. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alele, J. Jiang, J. F. Goldsmith, X. Yang, H. G. Maheshwari, R. A. Black, G. Baumann, and S. J. Frank Blockade of Growth Hormone Receptor Shedding by a Metalloprotease Inhibitor Endocrinology, April 1, 1998; 139(4): 1927 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung, M. J. Waters, I. Markus, W. R. Baumbach, and K. K. Y. Ho Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: A novel mechanism of growth hormone receptor regulation PNAS, October 14, 1997; 94(21): 11381 - 11386. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Kline and C. V. Clevenger Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk J. Biol. Chem., June 29, 2001; 276(27): 24760 - 24766. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, R. Guan, J. Jiang, J. J. Kopchick, R. A. Black, G. Baumann, and S. J. Frank Growth Hormone (GH)-induced Dimerization Inhibits Phorbol Ester-stimulated GH Receptor Proteolysis J. Biol. Chem., June 29, 2001; 276(27): 24565 - 24573. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |